PARP1/2 drugs for Ovarian Cancer

2 tracked PARP1/2 drugs in the Ovarian Cancer race. The class explanation lives on the PARP1/2 page; the full indication pipeline across every mechanism is on the Ovarian Cancer page.

1 approved / phase 41 Phase 2

Head-to-head evidence: Niraparib vs stenoparib

The roster

← all PARP1/2 drugs